NextGen Healthcare Introduces New Behavioral Health Suite
NextGen Healthcare, Inc. NXGN recently announced that the next generation of its behavioral health suite is available. This health suite, backed by a renowned electronic health record (EHR) and practice management system, is the industry’s only platform that combines comprehensive physical, behavioral and oral health in one software solution.
This new behavioral health suite is likely to boost NextGen’s broad solutions portfolio.
More on NextGen Behavioral Health Suite
Notably, this behavioral health suite is an upgraded software solution, which includes the most advanced capabilities from the company’s Topaz Information Solutions buyout (announced on Oct 23, 2019), with new features and specialized content.
This behavioral suite brings in packet navigation that will enable clinicians to define workflows without the need of outside assistance. Further, the suite will lower the total cost of ownership with the help of improved clinical content for targeted treatment. Apart from this, electronic medication administration record (eMAR) and bed board solutions will help clinicians in documenting inpatient and residential settings through single sign-on.
Per management, the introduction of this behavioral health suite comes at an important time as many people have been suffering from various behavioral health conditions during the COVID-19 pandemic. With this solution, there will be easy data exchange throughout the care continuum and mobile access, thereby enabling clinicians to offer informed care outside of a clinic or office setting.
Recent Developments
In Aug 2020, Virginia Cardiovascular Specialists — the largest private cardiology practice in Central Virginia — implemented NextGen Virtual Visits to extend care and treatment for non-urgent visits utilizing telehealth during the COVID-19 pandemic.
In July, NextGen announced that Nevada Eye Physicians, a comprehensive eye care facility in the Las Vegas area, is utilizing NextGen Enterprise with integrated telehealth capability called NextGen Virtual Visits.
In June, the company announced that Capital Women’s Care, OB/GYN private practice in the mid-Atlantic region, has utilized NextGen Virtual Visits for the expansion of women’s healthcare services during the pandemic.
Market Prospects
Per a report by Grand View Research, the global behaioral health care software and services market valued at $2.1 billion in 2019 and is anticipated to see a CAGR of 11.1% over the forecast period (2020-2027). Hence, the announcement of the availability of the health suite is a well-timed one.
Price Performance
Shares of this Zacks Rank #2 (Buy) company have lost 13% in a year’s time, against the industry’s growth of 30.7%.
Other Stocks to Consider
Some other top-ranked stocks from the broader medical space include West Pharmaceutical Services, Inc. WST, Thermo Fisher Scientific Inc. TMO and PerkinElmer, Inc. PKI. While PerkinElmer sports a Zacks Rank of 1 (Strong Buy), both Thermo Fisher and West Pharmaceuticals carry a Zacks Rank #2. You can see the complete list of today’s Zacks #1 Rank stocks here.
PerkinElmer has a projected long-term earnings growth rate of 17.4%.
West Pharmaceutical has a projected long-term earnings growth rate of 17.4%.
Thermo Fisher has an estimated long-term earnings growth rate of 15%.
Just Released: Zacks’ 7 Best Stocks for Today
Experts extracted 7 stocks from the list of 220 Zacks Rank #1 Strong Buys that has beaten the market more than 2X over with a stunning average gain of +24.3% per year.
These 7 were selected because of their superior potential for immediate breakout.
See these time-sensitive tickers now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
PerkinElmer, Inc. (PKI) : Free Stock Analysis Report
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
West Pharmaceutical Services, Inc. (WST) : Free Stock Analysis Report
NEXTGEN HEALTHCARE, INC (NXGN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
